Indian firm gets US FDA nod for brain tumors detection test

'TriNetra™-Glio' developed by Datar Cancer Genetics is a form of liquid biopsy which tests cells in the blood from brain tumors which are extremely rare and hard to detect

Sanjeev Kumar

This post is for paying subscribers only


Already have an account? Login